GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 172 filers reported holding GW PHARMACEUTICALS PLC in Q2 2017. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $82,000 | +70.8% | 475 | +11.8% | 0.02% | +72.7% |
Q1 2018 | $48,000 | -14.3% | 425 | 0.0% | 0.01% | -21.4% |
Q4 2017 | $56,000 | -33.3% | 425 | -48.5% | 0.01% | -33.3% |
Q3 2017 | $84,000 | -9.7% | 825 | -10.8% | 0.02% | -19.2% |
Q2 2017 | $93,000 | +447.1% | 925 | +516.7% | 0.03% | +420.0% |
Q1 2017 | $17,000 | 0.0% | 150 | 0.0% | 0.01% | 0.0% |
Q4 2016 | $17,000 | -79.3% | 150 | -83.3% | 0.01% | -82.1% |
Q2 2016 | $82,000 | +26.2% | 900 | 0.0% | 0.03% | +3.7% |
Q1 2016 | $65,000 | +4.8% | 900 | 0.0% | 0.03% | -53.4% |
Q4 2015 | $62,000 | – | 900 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |